SEC Company Response from Black Bird Biotech, Inc. (BBBT) (CIK 0001409999) — Sep 22, 2021
Black Bird Biotech, Inc. (BBBT) (CIK 0001409999)
Date: Sept. 22, 2021 · CIK: 0001409999 · Accession: 0001477932-21-006535
AI Filing Summary & Sentiment
File numbers found in text: 024-11621
Letter
VIA EDGAR Office of Manufacturing Division of Corporation Finance Securities and Exchange Commission Post-qualification Amendment to Offering Statement on Form 1-A (the “Post-Qualification Amendment”) Filed September 16, 2021 Commission File No. 024-11621
Dear Mr. Herbers:
On behalf of the Company, I respectfully request that the qualification date of the Post-Qualification Amendment be accelerated and that the Post-Qualification Amendment be declared qualified September 24, 2021, at 3:00 p.m. EST, or as soon thereafter as is reasonably practicable.
In making this request, the Company acknowledges the following:
-
should the Securities and Exchange Commission (the “Commission”) or the Staff, acting pursuant to delegated authority, declare the filing qualified, it does not foreclose the Commission from taking any action with respect to the filing;
-
the action of the Commission or the staff, acting pursuant to delegated authority, to declare the filing qualified does not relieve the Company from its full responsibility for the adequacy and accuracy of disclosure in the filing; and
-
the Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities law of the United States.
Very truly yours,
/s/ Fabian G. Deneault
Show Raw Text
CORRESP
1
filename1.htm
bbbt_corresp.htmBLACK BIRD BIOTECH, INC.
3505 Yucca Drive – Suite 104
Flower Mound, Texas 75028
September 22, 2021
VIA EDGAR
Mr. Gregory Herbers
Office of Manufacturing
Division of Corporation Finance
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:
Black Bird Biotech, Inc. (the “Company”)
Post-qualification Amendment to
Offering Statement on Form 1-A (the “Post-Qualification Amendment”)
Filed September 16, 2021
Commission File No. 024-11621
Dear Mr. Herbers:
On behalf of the Company, I respectfully request that the qualification date of the Post-Qualification Amendment be accelerated and that the Post-Qualification Amendment be declared qualified September 24, 2021, at 3:00 p.m. EST, or as soon thereafter as is reasonably practicable.
In making this request, the Company acknowledges the following:
-
should the Securities and Exchange Commission (the “Commission”) or the Staff, acting pursuant to delegated authority, declare the filing qualified, it does not foreclose the Commission from taking any action with respect to the filing;
-
the action of the Commission or the staff, acting pursuant to delegated authority, to declare the filing qualified does not relieve the Company from its full responsibility for the adequacy and accuracy of disclosure in the filing; and
-
the Company may not assert staff comments and/or qualification as a defense in any proceeding initiated by the Commission or any person under the federal securities law of the United States.
Very truly yours,
/s/ Fabian G. Deneault
Fabian G. Deneault
President
Black Bird Biotech, Inc.